finanzen.net

Zerenex in Japan! Zukunft v. Perifosine!

Seite 1 von 1
neuester Beitrag: 10.05.08 15:53
eröffnet am: 10.05.08 15:53 von: witchhunter6. Anzahl Beiträge: 1
neuester Beitrag: 10.05.08 15:53 von: witchhunter6. Leser gesamt: 2255
davon Heute: 1
bewertet mit 0 Sternen

10.05.08 15:53

138 Postings, 4672 Tage witchhunter666Zerenex in Japan! Zukunft v. Perifosine!

Commenting on the quarter, Michael S. Weiss, Keryx's Chairman and Chief
Executive Officer, said, "The first quarter of 2008 has been the most
challenging one for the Company since I joined back in 2002. However, with
the restructuring now substantially complete, I believe that Keryx is now
well-positioned to move Zerenex and Perifosine forward through advanced
clinical development." Weiss continued, "On the financial side, with
respect to our strategic licensing arrangement for Zerenex in Japan, the
Company has received an additional $8 million milestone payment from
JT/Torii and, coupled with our existing cash resources and reduced overhead
structure, we believe that we are well-positioned to focus our resources on
creating value in our drug candidates."

On Monday, May 12, 2008, at 8:30am EDT, the Company will host an
investor conference call to provide a brief financial overview of the
Company's first quarter financial results.
 

   Antwort einfügen - nach oben

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Daimler AG710000
Deutsche Bank AG514000
NEL ASAA0B733
Apple Inc.865985
Microsoft Corp.870747
Amazon906866
Volkswagen (VW) AG Vz.766403
CommerzbankCBK100
BASFBASF11
Infineon AG623100
SAP SE716460
Aurora Cannabis IncA12GS7
TUITUAG00
Allianz840400